Skip to content

BICYCLE THERAPEUTICS PLC

BCYC

CIK 0001761612 · Pharmaceutical Preparations · Nasdaq

  • BICYCLE THERAPEUTICS Ltd (until 2019-05-24)
← back to feed
Revenue (TTM)
$25.52M
+105.8% YoY Q1 Mar 2026
Net Income (TTM)
−$259.63M
−29.5% YoY Q1 Mar 2026
EPS Diluted (TTM)
−$3.74
−9.0% YoY Q1 Mar 2026
Gross Margin
—
Q1 Mar 2026
Operating Margin
-1,128.0%
Q1 Mar 2026
Net Margin
-1,017.4%
Q1 Mar 2026
Free Cash Flow (TTM)
−$273M
Q1 Mar 2026
Cash
$559.47M
Q1 Mar 2026
Total Debt
$30.91M
Q1 Mar 2026
Shares Outstanding
30.04M sh
Q1 Mar 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings